tiprankstipranks
Xvivo Perfusion AB (XVIPF)
OTHER OTC:XVIPF
US Market

Xvivo Perfusion AB (XVIPF) Financial Statements

Compare
10 Followers

Xvivo Perfusion AB Financial Overview

Xvivo Perfusion AB's market cap is currently $1.22B. The company's EPS TTM is $0.518; its P/E ratio is 73.96; Xvivo Perfusion AB is scheduled to report earnings on January 28, 2025, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 822.41Mkr 597.54Mkr 415.29Mkr 258.39Mkr 179.86M
Gross Profitkr 616.41Mkr 445.11Mkr 296.96Mkr 188.28Mkr 132.97M
Operating Incomekr 88.35Mkr 4.19Mkr 23.18Mkr 6.98Mkr -34.31M
EBITDAkr 88.35Mkr 126.57Mkr 39.21Mkr 39.20Mkr -43.33M
Net Incomekr 172.18Mkr 91.82Mkr 18.43Mkr 8.15Mkr -43.73M
Balance Sheet
Cash & Short-Term Investmentskr 415.52Mkr 546.09Mkr 246.54Mkr 398.70Mkr 353.44M
Total Assetskr 2.40Bkr 2.20Bkr 1.73Bkr 1.54Bkr 1.15B
Total Debtkr 0.00kr 31.44Mkr 10.01Mkr 5.72Mkr 7.21M
Net Debtkr -415.52Mkr -514.35Mkr -236.54Mkr -392.98Mkr -346.22M
Total Liabilitieskr 245.97Mkr 250.57Mkr 302.95Mkr 257.15Mkr 141.85M
Stockholders' Equitykr 2.16Bkr 1.95Bkr 1.43Bkr 1.29Bkr 1.01B
Cash Flow
Free Cash Flowkr 111.29Mkr -97.65Mkr -103.09Mkr -106.13Mkr -76.94M
Operating Cash Flowkr 111.29Mkr 46.29Mkr 27.86Mkr -12.06Mkr -12.27M
Investing Cash Flowkr -243.81Mkr -161.62Mkr -197.62Mkr -187.70Mkr -266.53M
Financing Cash Flowkr -10.90Mkr 418.55Mkr -6.84Mkr 234.61Mkr 482.77M
Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Xvivo Perfusion AB Debt to Assets

Xvivo Perfusion AB Cash Flow

Xvivo Perfusion AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis